You are here

RegeneRx

RegeneRx Eyes Pipeline Shuffle in Light of Development Delays

BioSpace

Mon, 08/22/22 - 08:27 pm

neurotrophic keratitis

U.S. Patent Office Significantly Extends the Term of Three RegeneRx Patents

Yahoo

Mon, 11/3/14 - 09:52 am

RegeneRx’s Strategic Partner G-treeBNT Preparing for Phase III Dry Eye Trials in Asia with RGN-259

Yahoo

Mon, 07/7/14 - 10:55 am

dry eye disease

RegeneRx says Phase 2 trial met primary outcome measure

Yahoo/Fly on the Wall

Mon, 06/24/13 - 10:42 am

epidermolysis bullosa

China Biotech In Review: GE Seeks To Increase China Revenues By Expanding Beyond Top Tier Markets

Seeking Alpha

Sun, 04/1/12 - 11:46 am

Chongqing Huapont Pharma

Hubei Minkang Pharma

RegeneRx Biopharmaceuticals Announces Proposed Public Offering

MarketWatch

Sat, 04/17/10 - 12:50 pm

RegeneRx Reports Phase II Venous Stasis Trial Results

Yahoo

Fri, 03/27/09 - 06:58 am

RegeneRx Updates on Phase II Venous Stasis Trial

Yahoo

Thu, 02/26/09 - 12:53 pm

RegeneRx to Shift Ophthalmic Clinical Development Strategy

Yahoo

Wed, 01/21/09 - 10:43 am

RegeneRx Reports Phase II Pressure Ulcer Trial Results

Yahoo

Fri, 01/9/09 - 10:10 am